In simple terms, Shanghai Junshi Biosciences Co., Ltd. has 2300.919 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep -0.229% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -4.727%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -4.426%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust -0.201% return, is a testament to Shanghai Junshi Biosciences Co., Ltd.'s adeptness in optimizing resource deployment. Shanghai Junshi Biosciences Co., Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.280%. Furthermore, the proficiency of Shanghai Junshi Biosciences Co., Ltd. in capital utilization is underscored by a remarkable -0.274% return on capital employed.
Stock Prices
Shanghai Junshi Biosciences Co., Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $12.6, while its low point bottomed out at $12.16. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Shanghai Junshi Biosciences Co., Ltd.'s stock market.
Liquidity Ratios
Analyzing 1877.HK liquidity ratios reveals its financial health of the firm.
The current ratio of 228.47% gauges short-term asset coverage for liabilities.
The quick ratio (175.17%) assesses immediate liquidity, while the cash ratio (155.36%) indicates cash reserves.
cards.indicator
cards.value
Current Ratio
228.47%
Quick Ratio
175.17%
Cash Ratio
155.36%
Profitability Ratios
1877.HK profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -482.99% underscores its earnings before tax deductions.
The effective tax rate stands at -5.99%, revealing its tax efficiency.
The net income per EBT, 91.65%, and the EBT per EBIT, 102.17%, provide insights into its earnings hierarchy.
Lastly, with an EBIT per revenue ratio of -472.71%, we grasp its operational profitability.
cards.indicator
cards.value
Pretax Profit Margin
-482.99%
Effective Tax Rate
-5.99%
Net Income per EBT
91.65%
EBT per EBIT
102.17%
EBIT per Revenue
-472.71%
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 2.28, it details the span from stock purchase to revenue.
The 2 days it takes to settle debts showcases its creditor relations.
Meanwhile, a 2 cash conversion cycle and 106.80% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.
cards.indicator
cards.value
Days of Sales Outstanding
175
Days of Inventory Outstanding
310
Operating Cycle
651.33
Days of Payables Outstanding
72
Cash Conversion Cycle
579
Receivables Turnover
1.07
Payables Turnover
5.07
Inventory Turnover
1.18
Fixed Asset Turnover
0.14
Asset Turnover
0.05
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -2.03, and free cash flow per share, -2.88, depict cash generation on a per-share basis.
The cash per share value, 3.84, showcases liquidity position.
A payout ratio of -0.01 highlights the portion of earnings distributed as dividends.
Lastly, the operating cash flow sales ratio, -3.88, offers insight into cash flow relative to sales.
cards.indicator
cards.value
Operating Cash Flow per Share
-2.03
Free Cash Flow per Share
-2.88
Cash per Share
3.84
Payout Ratio
-0.01
Operating Cash Flow Sales Ratio
-3.88
Free Cash Flow to Operating Cash Flow Ratio
1.42
Cash Flow Coverage Ratio
-1.14
Short Term Coverage Ratio
-3.71
Capital Expenditure Coverage Ratio
-2.41
Dividend Paid and Capex Coverage Ratio
-2.33
Debt and Leverage Ratios
Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 15.45%, highlights its total liabilities relative to assets.
With a debt-equity ratio of 0.25, we discern the balance between debt and equity financing.
The long-term debt to capitalization, 14.50%, and total debt to capitalization, 19.68%, ratios shed light on its capital structure.
cards.indicator
cards.value
Debt Ratio
15.45%
Debt Equity Ratio
0.25
Long Term Debt to Capitalization
14.50%
Total Debt to Capitalization
19.68%
Cash Flow to Debt Ratio
-1.14
Company Equity Multiplier
1.59
Per Share Data
Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 1.53, provides a glimpse into top-line earnings distributed across each share.
Net income per share, -2.32, reflects the portion of profit attributed to each share.
The book value per share, 7.27, represents the net asset value distributed per share, while the tangible book value per share, 6.88, excludes intangible assets.
cards.indicator
cards.value
Revenue Per Share
1.53
Net Income Per Share
-2.32
Book Value Per Share
7.27
Tangible Book Value Per Share
6.88
Shareholders Equity Per Share
7.27
Interest Debt Per Share
1.78
Capex Per Share
-0.85
Growth Ratios
Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 3.38%, indicates top-line expansion, while the gross profit growth, -6.37%, reveals profitability trends.
EBIT growth, 7.32%, and operating income growth, 7.32%, offer insights into operational profitability progression.
The net income growth, 11.57%, showcases bottom-line expansion, and the EPS growth, 17.44%, measures the growth in earnings per share.
cards.indicator
cards.value
Revenue Growth
3.38%
Gross Profit Growth
-6.37%
EBIT Growth
7.32%
Operating Income Growth
7.32%
Net Income Growth
11.57%
EPS Growth
17.44%
EPS Diluted Growth
17.44%
Weighted Average Shares Growth
7.28%
Weighted Average Shares Diluted Growth
7.28%
Operating Cash Flow Growth
-12.94%
Free Cash Flow Growth
-30.81%
10-Year Revenue Growth per Share
30794.30%
5-Year Revenue Growth per Share
98282.81%
3-Year Revenue Growth per Share
-21.32%
10-Year Operating CF Growth per Share
-736.26%
5-Year Operating CF Growth per Share
-140.07%
3-Year Operating CF Growth per Share
-11.72%
10-Year Net Income Growth per Share
-1236.64%
5-Year Net Income Growth per Share
-94.92%
3-Year Net Income Growth per Share
-14.49%
10-Year Shareholders Equity Growth per Share
389.93%
5-Year Shareholders Equity Growth per Share
31.64%
3-Year Shareholders Equity Growth per Share
2.24%
Receivables Growth
-6.65%
Inventory Growth
-10.18%
Asset Growth
-9.81%
Book Value per Share Growth
-29.84%
Debt Growth
32.62%
R&D Expense Growth
-18.74%
SGA Expenses Growth
8.13%
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 15,301,383,606.481, captures the company's total value, considering both debt and equity.
Income quality, 0.88, assesses the reliability of reported earnings.
The sales, general, and administrative to revenue ratio, 0.36, gauges operational efficiency, while the research and development to revenue, 128.95%, highlights investment in innovation.
The ratio of intangibles to total assets, 4.82%, indicates the value of non-physical assets, and capex to operating cash flow, 41.53%, measures reinvestment capability.
cards.indicator
cards.value
Enterprise Value
15,301,383,606.481
Income Quality
0.88
Sales General and Administrative to Revenue
0.36
Research and Development to Revenue
128.95%
Intangibles to Total Assets
4.82%
Capex to Operating Cash Flow
41.53%
Capex to Revenue
-55.41%
Capex to Depreciation
-274.00%
Stock-Based Compensation to Revenue
1.60%
Graham Number
19.47
Return on Tangible Assets
-21.15%
Graham Net Net
0.40
Working Capital
3,132,677,519
Tangible Asset Value
6,773,645,882
Net Current Asset Value
1,548,818,698
Average Receivables
500,448,971.5
Average Payables
203,395,731
Average Inventory
568,536,905.5
Days Sales Outstanding
117
Days Payables Outstanding
72
Days of Inventory On Hand
310
ROIC
-28.30%
ROE
-0.32%
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 1.35, and the price to book ratio, 1.35, reflect the market's valuation relative to the company's book value.
The price to sales ratio, 43.37, provides a perspective on valuation in relation to sales.
Ratios like price to free cash flows, -7.89, and price to operating cash flows, -4.83, gauge market valuation against cash flow metrics.
cards.indicator
cards.value
Price Book Value Ratio
1.35
Price to Book Ratio
1.35
Price to Sales Ratio
43.37
Price Cash Flow Ratio
-4.83
Price Earnings to Growth Ratio
0.03
Enterprise Value Multiple
-10.82
Price Fair Value
1.35
Price to Operating Cash Flow Ratio
-4.83
Price to Free Cash Flows Ratio
-7.89
Price to Tangible Book Ratio
2.42
Enterprise Value to Sales
10.18
Enterprise Value Over EBITDA
-6.91
EV to Operating Cash Flow
-7.63
Earnings Yield
-13.17%
Free Cash Flow Yield
-16.37%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
